Abstract
Antifungal susceptibility testing is a progressive field of mycology with respect to dermatophytes as well as non-dermatophytes. Documentation and approval regarding standardisation of in vitro susceptibility testing have been done by different governing bodies such as Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing and British Society of Antimicrobial Chemotherapy. The process of standardisation and approval started in 1985 with certain amendments in 2002 and 2004. In case of dermatophytes, antifungal susceptibility testing protocol has been approved recently in 2008; however, the approved standardisation also needs certain amendments/modifications due to the limitations of an existing method. In the present review, we have compiled these standardisation techniques along with the limitations and advantages and the amendments that have been proposed at different time periods by different researchers and regulatory agencies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
